T-cell prolymphocytic leukemia: Update and focus on alemtuzumab (Campath-1H)

Hematology

Volumn 8, Issue 1, 2003, Pages 1-6

  Cao, Thai M ^a   Coutre, Steven E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Campath 1H; Chromosome; Prolymphocytic leukemia; Review

Indexed keywords

ALEMTUZUMAB; ALKYLATING AGENT; ANTILEUKEMIC AGENT; CHLORAMBUCIL; CLADRIBINE; FLUDARABINE; PENTOSTATIN;

BONE MARROW SUPPRESSION; BRONCHOSPASM; CANCER SURVIVAL; CHROMOSOME 14Q; CHROMOSOME ABERRATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE COURSE; DRUG USE; FEVER; HUMAN; HYPOTENSION; LABORATORY DIAGNOSIS; LEUKEMIA REMISSION; LEUKEMOGENESIS; LYMPHOCYTOPENIA; LYMPHOPROLIFERATIVE DISEASE; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; REVIEW; RIGOR; T CELL LEUKEMIA;

EID: 0037295911     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/1024533021000059465     Document Type: Review

References (39)

1. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. and Bloomfield, C.D. (2000) "The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November, 1997", Hematol. J. 1, 53-66.
2. Thiel, E., Bauchinger, M., Rodt, H., Huhn, D., Theml, H. and Thierfelder, S. (1977) "Evidence for monoclonal proliferation in prolymphocytic leukemia of T-cell origin. A cytogenetic and quantitative immunoautoradiographic analysis", Blut 35, 427-436.
3. Turchini, M.F., Geneix, A., Travade, P., Delarocque, A., Chassagne, J., Mathe, O. and Malet, P. (1984) "Cytogenetic studies in a case of T-cell prolymphocytic leukemia", Cancer Genet. Cytogenet. 12, 171-174.
4. Brito-Babapulle, V., Pomfret, M., Matutes, E. and Catovsky, D. (1987) "Cytogenetic studies on prolymphocytic leukemia II. T cell prolymphocytic leukemia", Blood 70, 926-931.
5. Heinonen, K., Mahlamaki, E., Hamalainen, E., Nousiainen, T. and Mononen, I. (1994) "Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia", Cancer Genet. Cytogenet. 78, 28-35.
6. Maljaei, S.H., Brito-Babapulle, V., Hiorns, L.R. and Catovsky, D. (1998) "Abnormalities of chromosomes 8, 11, 14 and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization", Cancer Genet. Cytogenet. 103, 110-116.
7. Virgilio, L., Isobe, M., Narducci, M.G., Carotenuto, P., Camerini, B., Kurosawa, N., Abbas ar, R., Croce, C.M. and Russo, G. (1993) "Chromosome walking on the TCL1 locus involved in T-cell neoplasia", Proc. Natl Acad. Sci. USA 90, 9275-9279.
8. Fu, T.B., Virgilio, L., Narducci, M.G., Facchiano, A., Russo, G. and Croce, C.M. (1994) "Characterization and localization of the TCL-1 oncogene product", Cancer Res. 54, 6297-6301.
9. Virgilio, L., Narducci, M.G., Isobe, M., Billips, L.G., Cooper, M.D., Croce, C.M. and Russo, G. (1994) "Identification of the TCL1 gene involved in T-cell malignancies", Proc. Natl Acad. Sci. USA 91, 12530-12534.
10. Roos, J., Hennig, I., Schwaller, J., Zbaren, J., Dummer, R., Burg, G., Tobler, A., Virgilio, L., Croce, C.M., Fey, M.F. and Borisch, B. (2001) "Expression of TCL1 in hematologic disorders", Pathobiology 69, 59-66.
11. Virgilio, L., Lazzeri, C., Bichi, R., Nibu, K., Narducci, M.G., Russo, G., Rothstein, J.L. and Croce, C.M. (1998) "Deregulated expression of TCL1 causes T-cell leukemia in mice", Proc. Natl Acad. Sci. USA 95, 3885-3889.
12. Kunstle, G., Laine, J., Pierron, G., Kagami Si, S., Nakajima, H., Hoh, F., Roumestand, C., Stern, M.H. and Noguchi, M. (2002) "Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1", Mol. Cell. Biol. 22, 1513-1525.
13. Laine, J., Kunstle, G., Obata, T. and Noguchi, M. (2002) "Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family", J. Biol. Chem. 277, 3743-3751.
14. Pekarsky, Y., Koval, A., Hallas, C., Bichi, R., Tresini, M., Malstrom, S., Russo, G., Tsichlis, P. and Croce, C.M. (2000) "Tcl1 enhances Akt kinase activity and mediates its nuclear translocation", Proc. Natl Acad. Sci. USA 97, 3028-3033.
15. Bartlett, N.L. and Longo, D.L. (1999) "T-small lymphocyte disorders", Semin. Hematol. 36, 164-170.
16. Matutes, E., Brito-Babapulle, V., Swansbury J., Ellis, J., Morilla, R., Dearden, C., Sempere, A. and Catovsky, D. (1991) "Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia", Blood 78, 3269-3274.
17. Jennings, C.D. and Foon, K.A. (1997) "Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy", Blood 90, 2863-2892.
18. Foa, R., Pelicci, P.G., Migone, N., Lauria, F., Pizzolo, G., Flug, F., Knowles, D.M. and Dalla-Favera, 2nd, R. (1986) "Analysis of T-cell receptor beta chain (T beta) gene rearrangements demonstrates the monoclonal nature of T-cell chronic lymphoproliferative disorders", Blood 67, 247-250.
19. Sugimoto, T., Imoto, S., Matsuo, Y., Kojima, K., Yasukawa, M., Murayama, T., Kohfuku, J., Mizuno, I., Yakushijin, K., Sada, A., Nishimura, R. and Koizumi, T. (2001) "T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype", Ann. Hematol. 80, 749-751.
20. Lamy, T. and Loughran, T.P. (1998) "Large granular lymphocyte leukemia", Cancer Control 5, 25-33.
21. Glass, L.F., Keller, K.L., Messina, J.L., Dalton, J., Yag-Howard, C. and Fenske, N.A. (1998) "Cutaneous T-cell lymphoma", Cancer Control 5, 11-18.
22. Dahmoush, L., Hijazi, Y., Barnes, E., Stetler-Stevenson, M. and Abati, A. (2002) "Adult T-cell leukemia/lymphoma: a cytopathologic, immunocytochemical, and flow cytometric study", Cancer 96, 110-116.
23. Garand, R., Goasguen, J., Brizard, A., Buisine, J., Charpentier, A., Claisse, J.F., Duchayne, E., Lagrange, M., Segonds, C., Troussard, X. and Flandrin, G. (1998) "Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Francais d'Hematologie Cellulaire", Br. J. Haematol. 103, 488-494.
24. Domingo-Domenech, E., Gonzalez-Barca, E., Salar, A., Claros, A.D. and Granena, A. (1999) "Indolent course as presentation in t-prolymphocytic leukaemia", Br. J. Haematol. 105, 840.
25. Palomera, L., Domingo, J.M., Agullo, J.A. and Soledad Romero, M. (1995) "Complete remission in T-cell prolymphocytic leukemia with 2-chlorodeoxyadenosine", J. Clin. Oncol. 13, 1284-1285.
26. Islam, A., Majer, R., Cumber, P. and Poynton, C. (1996) "Chlorambucil and prednisolone therapy in a patient with T-cell chronic lymphocytic leukaemia", Clin. Lab. Haematol. 18, 125-126.
27. Mercieca, J., Matutes, E., Dearden, C., MacLennan, K. and Catovsky, D. (1994) "The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype", J. Clin. Oncol. 12, 2588-2593.
28. Ginaldi, L., De Martinis, M., Matutes, E., Farahat, N., Morilla, R., Dyer, M.J. and Catovsky, D. (1998) "Levels of expression of CD52 in normal and leukemic B and T-cells: correlation with in vivo therapeutic responses to Campath-1H", Leuk. Res. 22, 185-191.
29. Pawson, R., Dyer, M.J., Barge, R., Matutes, E., Thornton, P.D., Emmett, E., Kluin-Nelemans, J.C., Fibbe, W.E., Willemze, R. and Catovsky, D. (1997) "Treatment of T-cell prolymphocytic leukemia with human CD52 antibody", J. Clin. Oncol. 15, 2667-2672.
30. Keating, M.J., Cazin, B., Coutre, S., Birhiray, R., Kovacsovics, T., Langer, W., Leber, B., Maughan, T., Rai, K., Tjonnfjord, G., Bekradda, M., Itzhaki, M. and Herait, P. (2002) "Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed", J. Clin. Oncol. 20, 205-213.
31. Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. and Rai, K.R. (1996) "National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment", Blood 87, 4990-4997.
32. Coutre, S., Rai, K., Keating, M., Gribben, J.G., Flinn, I., Rabinow, S. and Rizzierie, D. (2001) "Efficacy and safety of alemtuzumab (Campath-1H) used on a compassionate basis in refractory T-PLL (abstract)", Blood 98, 1542a.
33. Campath Prescribing Information. Berlex Laboratories, Inc. May 2001, Richmond, California.
34. Nguyen, D.D., Cao, T.M., Dugan, K., Starcher, S.A., Fechter, R.L. and Coutre, S.E. (2002) "Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia", Clin. Lymphoma 3, 105-110.
35. Collins, R.H., Pineiro, L.A., Agura, E.D. and Fay, J.W. (1998) "Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation", Bone Marrow Transplant. 21, 627-628.
36. Billio, A., Pescosta, N., Rosanelli, C., Fabris, P. and Coser, P. (2000) "A brief intensive chemotherapy in T-prolymphocytic leukemia", Haematologica 85, 438-439.
37. Garderet, L., Bittencourt, H., Kaliski, A., Daniel, M., Ribaud, P., Socie, G. and Gluckman, E. (2001) "Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation", Eur. J. Haematol. 66, 137-139.
38. Dearden, C.E., Matutes, E., Cazin, B., Tjonnfjord, G.E., Parreira, A., Nomdedeu, B., Leoni, P., Clark, F.J., Radia, D., Rassam, S.M., Roques, T., Ketterer, N., Brito-Babapulle, V., Dyer, M.J. and Catovsky, D. (2001) "High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H", Blood 98, 1721-1726.
39. Keating, M.J., O'Brien, S. and Albitar, M. (2002) "Emerging information on the use of rituximab in chronic lymphocytic leukemia", Semin. Oncol. 29, 70-74.